Trials / Recruiting
RecruitingNCT05475574
Impact of Discontinuing Contact Precautions for Extended-spectrum β-lactamase Enterobacteriaceae in a Geriatric Unit
Impact of Discontinuing Contact Precautions for Extended-spectrum β-lactamase Enterobacteriaceae (ESBLE) in a Geriatric Unit: an Interventional Prospective Noninferiority Non-randomized Double-blind Controlled Before and After Study
- Status
- Recruiting
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 954 (estimated)
- Sponsor
- Centre Hospitalier Régional Metz-Thionville · Academic / Other
- Sex
- All
- Age
- 65 Years
- Healthy volunteers
- Not accepted
Summary
This is an interventional multicenter prospective noninferiority non-randomized double-blind controlled before and after study. The aim of this study is to demonstrate that standard precautions alone are not inferior to contact precautions by comparing the incidence density of extended-spectrum β-lactamase (ESBL)-producing Enterobacteriaceae acquired in geriatric units before and after discontinuing contact precautions.
Detailed description
Healthcare-associated infections (HAIs) are one of the main causes of morbidity and mortality worldwide. Extended-spectrum β-lactamase (ESBL)-producing Enterobacteriaceae have become microorganisms frequently found in HAIs, which reduces the therapeutic possibilities.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | Discontinuation of contact precautions for ESBLE | Discontinuation of contact precaution : only standard precaution are implemented for any patient carrying (infected or colonized) ESBLE |
Timeline
- Start date
- 2023-03-07
- Primary completion
- 2029-09-07
- Completion
- 2029-09-21
- First posted
- 2022-07-27
- Last updated
- 2025-04-27
Locations
1 site across 1 country: France
Source: ClinicalTrials.gov record NCT05475574. Inclusion in this directory is not an endorsement.